|
|
Volumn 5, Issue 9, 1996, Pages 1183-1199
|
|
Nevirapine: A review of its development, pharmacological profile and potential for clinical use
a
|
|
Author keywords
Antiretroviral activity; HIV infection; HIV 1 reverse transcriptase; Nevirapine; Nonnucleoside reverse transcriptase inhibitor
|
|
Indexed keywords
CD4 ANTIGEN;
CYTOCHROME P450 ISOENZYME;
DAPSONE;
DIDANOSINE;
KETOCONAZOLE;
NEVIRAPINE;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RIFABUTIN;
RIFAMPICIN;
RNA DIRECTED DNA POLYMERASE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SULFAMETHOXAZOLE;
TRIMETHOPRIM;
VIRUS ENZYME;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG RESISTANCE;
DRUG SELECTIVITY;
HEADACHE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIVER DYSFUNCTION;
LYMPHOCYTE SUBPOPULATION;
ORAL DRUG ADMINISTRATION;
RASH;
RETROVIRUS;
REVIEW;
|
|
EID: 0029761518
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.9.1183 Document Type: Review |
|
Times cited : (124)
|
|
References (0)
|
